Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Vaccine Adjuvants Market, 2021 - Increasing Use Of Recombinant Subunit And Synthetic Vaccines - Research and Markets

Research and Markets
Posted on: 23 Aug 16

Research and Markets has announced the addition of the "Global Vaccine Adjuvants Market" report to their offering.

The global market for Vaccine Adjuvants was estimated to be worth USD 4,100 million, in the year 2016. It poised to reach USD 5,565 million by the end of 2021, growing at an estimated CAGR of 6.3% during the forecast period of 2016-2021

The Adjuvants are pharmacological or immunological agents that helps in synergizing and directing the adaptive immune response to vaccine agents. Adjuvants are generally classified based on their source, mechanism of action and physical or chemical properties. Adjuvants can be broadly classified into three groups that is active immunostimulants, carriers, and vehicle adjuvants.

Understanding the application of adjuvants is very imperative in analyzing the market dynamics. This study targets at gaining a detailed overview of the market dynamics of the contemporary market and during the forecast period for the vaccine adjuvants market. Adjuvants basically enhance the specific immune response against co-inoculated antigens.

The Adjuvants market in study has been segmented based on type and mechanism of action. The segmentation based on type includes Mineral Salt based adjuvants, Tensoactive agents, Emulsions, Liposomes, Carbohydrate adjuvants, Bacterial Products, Non-Bacterial organics (Squalene), Saponins, Cytokines, Virosomes, TLR based adjuvants, and Others.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Market Dynamics

4. Market Segmentation

5. Competitive Landscape

6. Company Profiles

7. Analyst Outlook For Investment Opportunity

8. Future Outlook Of The Market

Companies Featured

  • Invivogen
  • Sigma Aldrich
  • Seppic
  • Oz Biosciences
  • Novavax
  • Adjuvatis
  • Adjuvance Technologies
  • Vaxliant
  • Vaxine

For more information about this report visit

Related Topics: Vaccines

View source version on

Business Wire

Last updated on: 23/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.